Loading...

NuCana plc

NCNANASDAQ
Healthcare
Biotechnology
$0.06
$-0.02(-27.36%)

NuCana plc NCNA Peers

See (NCNA) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
NCNA$0.06-27.36%520.3K-0.02-$5.09N/A
VRTX$444.33+0.21%113.3B-114.92-$3.84N/A
REGN$521.68+0.13%55.3B13.24$39.35+0.17%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$323.63+1.69%42.1B-153.00-$2.11N/A
ARGX$531.75-5.05%34.2B34.18$16.39N/A
BNTX$106.63+0.46%25.7B-29.16-$3.66N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
RPRX$35.88+1.73%20.2B14.64$2.45+2.42%
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

NCNA vs VRTX Comparison

NCNA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NCNA stands at 520.3K. In comparison, VRTX has a market cap of 113.3B. Regarding current trading prices, NCNA is priced at $0.06, while VRTX trades at $444.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NCNA currently has a P/E ratio of -0.02, whereas VRTX's P/E ratio is -114.92. In terms of profitability, NCNA's ROE is -3.20%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, NCNA is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for NCNA.

Stock Price Comparison

Loading...

Frequently Asked Questions

;